These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9402460)

  • 1. C-reactive protein and complement in myocardial infarction and postinfarction heart failure.
    Beranek JT
    Eur Heart J; 1997 Nov; 18(11):1834-6. PubMed ID: 9402460
    [No Abstract]   [Full Text] [Related]  

  • 2. C-reactive protein and heart failure after myocardial infarction in the community.
    Bursi F; Weston SA; Killian JM; Gabriel SE; Jacobsen SJ; Roger VL
    Am J Med; 2007 Jul; 120(7):616-22. PubMed ID: 17602936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum C-reactive protein and complement proteins in patients with acute myocardial infarction.
    Halas YA; Rahal E; Abdelnoor AM; Haddad R; Abchee A
    Immunopharmacol Immunotoxicol; 2005; 27(3):405-16. PubMed ID: 16237952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for heart failure in patients with one prior myocardial infarction episode.
    Mocan T; Agoşton-Coldea L; Gatfossé M; Rosenstingl S; Mocan LC
    Rom J Intern Med; 2008; 46(3):213-21. PubMed ID: 19366080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction.
    Lagrand WK; Niessen HW; Wolbink GJ; Jaspars LH; Visser CA; Verheugt FW; Meijer CJ; Hack CE
    Circulation; 1997 Jan; 95(1):97-103. PubMed ID: 8994423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative C reactive protein levels and acute myocardial infarction complications in a Hispanic population: an observational analytical pilot study.
    Rentas E; Pérez Arzola M; Bredy R
    Bol Asoc Med P R; 2006; 98(4):284-9. PubMed ID: 19610570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgM colocalises with complement and C reactive protein in infarcted human myocardium.
    Krijnen PA; Ciurana C; Cramer T; Hazes T; Meijer CJ; Visser CA; Niessen HW; Hack CE
    J Clin Pathol; 2005 Apr; 58(4):382-8. PubMed ID: 15790702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction.
    Latini R; Maggioni AP; Peri G; Gonzini L; Lucci D; Mocarelli P; Vago L; Pasqualini F; Signorini S; Soldateschi D; Tarli L; Schweiger C; Fresco C; Cecere R; Tognoni G; Mantovani A;
    Circulation; 2004 Oct; 110(16):2349-54. PubMed ID: 15477419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin binding in cardiomyopathic hearts.
    Das SK; Callen JP; Dodson VN; Cassidy JT
    Circulation; 1971 Oct; 44(4):612-6. PubMed ID: 4106155
    [No Abstract]   [Full Text] [Related]  

  • 10. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein.
    Suleiman M; Khatib R; Agmon Y; Mahamid R; Boulos M; Kapeliovich M; Levy Y; Beyar R; Markiewicz W; Hammerman H; Aronson D
    J Am Coll Cardiol; 2006 Mar; 47(5):962-8. PubMed ID: 16516078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New markers of progression of chronic heart failure in patients with myocardial infarction, type 2 diabetes and obesity].
    Kravchun PP; Kadykova OI; Gabisonia TN
    Georgian Med News; 2015 Jan; (238):60-4. PubMed ID: 25693216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renaissance of C reactive protein.
    Pepys MB; Berger A
    BMJ; 2001 Jan; 322(7277):4-5. PubMed ID: 11141130
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA-365 expression in the serum of patients with heart failure with reduced ejection fraction after myocardial infarction.
    Wu HB; Wang YC; Yao WJ; Xie YT; Wang XC; Du RP
    Am J Emerg Med; 2021 Jul; 45():645-646. PubMed ID: 33214020
    [No Abstract]   [Full Text] [Related]  

  • 14. Soluble-complex formation after myocardial infarction.
    Versey JM; Gabriel R
    Lancet; 1974 Aug; 2(7879):493-4. PubMed ID: 4137193
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathogenesis of heart failure in myocardial infarct].
    Sibirskiĭ VIu; Nechaev DD; Lukin IuD; Martynov IV; Degtiareva IA
    Klin Med (Mosk); 1987 Sep; 65(9):59-62. PubMed ID: 3121911
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of plasma renin activity levels in patients with and without congestive heart failure after myocardial infarction.
    Sanders JB; Cunningham SG; Knowlton CG
    Heart Lung; 1985 Jan; 14(1):1-8. PubMed ID: 3881367
    [No Abstract]   [Full Text] [Related]  

  • 17. A murine model for studying hematopoiesis and immunity in heart failure.
    Iversen PO; Sørensen DR
    Methods Mol Biol; 2007; 360():269-75. PubMed ID: 17172734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRP, a major culprit in complement-mediated tissue damage in acute myocardial infarction?
    Nijmeijer R; Lagrand WK; Visser CA; Meijer CJ; Niessen HW; Hack CE
    Int Immunopharmacol; 2001 Mar; 1(3):403-14. PubMed ID: 11367525
    [No Abstract]   [Full Text] [Related]  

  • 19. C-reactive protein in ischaemic cardiomyopathy: assessing vascular risk in heart failure.
    Dickstein K
    Eur Heart J; 2005 Nov; 26(21):2218-9. PubMed ID: 16195321
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunologic aspects of ischemic heart disease in women of reproductive age].
    Zemánková J; Lokaj J; Klabusay L
    Vnitr Lek; 1984 Aug; 30(8):732-9. PubMed ID: 6506494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.